Publications

Overall Survival Results from a Phase Iii Trial of Trifluridine/Tipiracil (Ftd/Tpi) Vs Placebo in Patients (Pts) with Metastatic Gastric Cancer Refractory to Standard Therapies (Tags)

AuthID
P-00R-X18

Author(s)

Shitara, K

Tabernero, J

Dvorkin, M

Mansoor, W

Arkenau, HT

Prokharau, A

Alsina, M

Ghidini, M

Faustino, C

Gorbunova, V

Zhavrid, E

Nishikawa, K

Hosokawa, A

Ganea, D

Yalçın, Ş

Fujitani, K

Beretta, G

Winkler, R

Doi, T

Ilson, DH

Document Type

Article

Year published

2018

Published

in Annals of Oncology, ISSN: 0923-7534

Volume: 29, Pages: ix55

Indexing

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1093/annonc/mdy432.027

Pubmed: 32178068

Scopus: 2-s2.0-85081592621

Source Identifiers

ISSN: 0923-7534

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Overall Survival Results from a Phase Iii Trial of Trifluridine/Tipiracil (Ftd/Tpi) Vs Placebo in Patients (Pts) with Metastatic Gastric Cancer Refractory to Standard Therapies (Tags)

Useful Links

Get Help

Federated Authentication (Click on the image)

Overall Survival Results from a Phase Iii Trial of Trifluridine/Tipiracil (Ftd/Tpi) Vs Placebo in Patients (Pts) with Metastatic Gastric Cancer Refractory to Standard Therapies (Tags)

Useful Links

Get Help